Crossref
Differential Cytotoxic Activity of a New Cationic Pd(II) Coordination Compound with N4-Tetradentate Hybrid Ligand in Cancer Cell Lines
Experimed · 2022
DOI: 10.26650/experimed.1188586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimed, 2022. Verfasst von Merve Erkısa Genel und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Genel, M. E., Selvi, S., Yılmaz, İ., Akar, R., Yaylım, İ., Şengül, A., & Ulukaya, E. (2022). Differential Cytotoxic Activity of a New Cationic Pd(II) Coordination Compound with N4-Tetradentate Hybrid Ligand in Cancer Cell Lines. Experimed. https://doi.org/10.26650/experimed.1188586
Vancouver
Genel ME, Selvi S, Yılmaz İ, Akar R, Yaylım İ, Şengül A, et al. Differential Cytotoxic Activity of a New Cationic Pd(II) Coordination Compound with N4-Tetradentate Hybrid Ligand in Cancer Cell Lines. Experimed. 2022. doi:10.26650/experimed.1188586
BibTeX
@article{Genel2022,
author = {Genel, Merve Erkısa and Selvi, Selin and Yılmaz, İsmail and Akar, Remzi and Yaylım, İlhan and Şengül, Abdurrahman and Ulukaya, Engin},
title = {Differential Cytotoxic Activity of a New Cationic Pd(II) Coordination Compound with N4-Tetradentate Hybrid Ligand in Cancer Cell Lines},
journal = {Experimed},
year = {2022},
doi = {10.26650/experimed.1188586}
}
EUVIMED